Thomas Des Rosier Seres Therapeutics, Inc. (MCRB) insider trading activity

MCRB Quotes by TradingView

Thomas Des Rosier is Chief Legal Officer and EVP of Seres Therapeutics, Inc.. Currently has a direct ownership of 135,192 shares of MCRB, which is worth approximately $104,097. The most recent transaction as insider was on Nov 18, 2024, when has been sold 878 shares (Common Stock) at a price of $0.54 per share, resulting in proceeds of $474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 135K
8.87% 3M change
18.7% 12M change
Total Value Held $104,097

Thomas DesRosier Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Open market or private sale
$474 $0.54 p/Share
878 Reduced 0.65%
135,192 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
-
2,656 Added 1.91%
136,070 Common Stock
Oct 28 2024
SELL
Open market or private sale
$2,938 $0.69 p/Share
4,259 Reduced 3.09%
133,414 Common Stock
Oct 27 2024
BUY
Exercise of conversion of derivative security
-
13,500 Added 8.93%
137,673 Common Stock
Aug 16 2024
SELL
Open market or private sale
$733 $0.84 p/Share
873 Reduced 0.7%
124,173 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
2,656 Added 2.08%
125,046 Common Stock
May 15 2024
SELL
Open market or private sale
$792 $0.94 p/Share
843 Reduced 0.68%
122,390 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
2,656 Added 2.11%
123,233 Common Stock
Feb 16 2024
SELL
Open market or private sale
$4,254 $1.08 p/Share
3,939 Reduced 3.16%
120,577 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
10,625 Added 7.86%
124,516 Common Stock
Oct 30 2023
SELL
Open market or private sale
$5,610 $1.35 p/Share
4,156 Reduced 3.52%
113,891 Common Stock
Oct 27 2023
BUY
Exercise of conversion of derivative security
-
13,501 Added 10.26%
118,047 Common Stock
Jul 05 2022
BUY
Grant, award, or other acquisition
$200,000 $3.15 p/Share
63,492 Added 37.78%
104,546 Common Stock
TD

Thomas Des Rosier

Chief Legal Officer and EVP
Cambridge, MA

Track Institutional and Insider Activities on MCRB

Follow Seres Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

News

Receive news related to Seres Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MCRB